1. Home
  2. TVTX vs DHT Comparison

TVTX vs DHT Comparison

Compare TVTX & DHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • DHT
  • Stock Information
  • Founded
  • TVTX 2008
  • DHT 2005
  • Country
  • TVTX United States
  • DHT Bermuda
  • Employees
  • TVTX N/A
  • DHT N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • DHT Marine Transportation
  • Sector
  • TVTX Health Care
  • DHT Consumer Discretionary
  • Exchange
  • TVTX Nasdaq
  • DHT Nasdaq
  • Market Cap
  • TVTX 1.7B
  • DHT 1.6B
  • IPO Year
  • TVTX N/A
  • DHT 2005
  • Fundamental
  • Price
  • TVTX $20.44
  • DHT $11.02
  • Analyst Decision
  • TVTX Strong Buy
  • DHT Strong Buy
  • Analyst Count
  • TVTX 14
  • DHT 4
  • Target Price
  • TVTX $33.31
  • DHT $13.75
  • AVG Volume (30 Days)
  • TVTX 1.6M
  • DHT 1.7M
  • Earning Date
  • TVTX 05-01-2025
  • DHT 05-06-2025
  • Dividend Yield
  • TVTX N/A
  • DHT 7.37%
  • EPS Growth
  • TVTX N/A
  • DHT 4.76
  • EPS
  • TVTX N/A
  • DHT 1.10
  • Revenue
  • TVTX $273,533,000.00
  • DHT $563,104,000.00
  • Revenue This Year
  • TVTX $68.31
  • DHT N/A
  • Revenue Next Year
  • TVTX $55.65
  • DHT $25.01
  • P/E Ratio
  • TVTX N/A
  • DHT $10.12
  • Revenue Growth
  • TVTX 75.65
  • DHT N/A
  • 52 Week Low
  • TVTX $6.01
  • DHT $8.67
  • 52 Week High
  • TVTX $25.29
  • DHT $12.80
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 61.49
  • DHT 57.57
  • Support Level
  • TVTX $19.84
  • DHT $9.91
  • Resistance Level
  • TVTX $22.07
  • DHT $11.43
  • Average True Range (ATR)
  • TVTX 1.11
  • DHT 0.30
  • MACD
  • TVTX 0.42
  • DHT 0.09
  • Stochastic Oscillator
  • TVTX 77.85
  • DHT 73.03

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About DHT DHT Holdings Inc.

DHT Holdings Inc is a crude oil tanker company. It is an independent crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC. It generates revenues from time charter and spot market operations. Its fleets consist of very large crude carriers known as VLCCs that range in size from 270,000 to 320,000 deadweight tons. Geographically, DHT operates in Monaco, Oslo, Norway, and Singapore. The company generates the majority of its revenue from the shipping revenues.

Share on Social Networks: